IFI-M · CB Sequential Integration Series

Specimen SS-F-M2-04886 // MULTI-AXIS · IFI-M

CB Sequential Integration Series III-AG-B

Mentha × piperita

Peppermint

Tier IIICB Sequential Integration Series

Target Trait

2.69×

fold-change

Cooling+Bitter-Attenuation sequential pathway fold-change

Technical Specifications

SKU

SS-F-M2-04886

Genomic Edits

9

GC Content

44.7%

Construct Length

4,775 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

TRPM8 + TAS2R38 (suppression)

IFI Score

269

Pathway Edits

  • TRPM8 pathway primary gene cluster overexpression for cooling axis activation
  • TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
  • Bidirectional promoter system for synchronized C+B dual-axis co-expression
  • Metabolic flux partitioning between IFI-C and IFI-B pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Cooling-Bitter-Attenuation combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for C+B simultaneous accumulation
  • Cofactor balance optimization for C+B dual-pathway operation
  • Protein scaffold engineering for C+B enzyme co-localization

Key Interventions

Dual-receptor co-activation via synchronized TRPM8 and TAS2R38 (suppression) pathway engineeringMetabolic flux partitioning strategy enabling simultaneous cooling and bitter-attenuation accumulation without competing pathway suppressionSequential construct stacking for CB multi-axis integrationT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III CB dual-axis sequential integration platform for food ingredient applications requiring verified combined cooling+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$1549 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities